SenesTech, a Flagstaff, Ariz.-based developer of proprietary technologies for managing animal pest populations through fertility control, has hired Dr. Sandra Alcaraz as vice president of regulatory affairs.
Dr. Alcaraz is experienced in biological sciences, international regulatory affairs, and the development and marketing of disruptive technologies and novel products. She has a special expertise in launching new products that are considered “disruptive” because of their significant market impact.
Most recently, Dr. Alcaraz was the disruptive technologies manager for Gowan Co., a multinational developer and marketer of innovative crop protection products. Prior to that, she was a biological research scientist. Dr. Alcaraz has a bachelor’s in biology from Pontificia Universidad Javeriana in Colombia, and master’s and doctoral degrees in entomology from The Ohio State University.
“I look forward to assisting SenesTech in the registering of ContraPest worldwide, as it is truly a technology with the potential of revolutionizing rodent control practices everywhere in the world,” she says.
The company recently received registration by the U.S. Environmental Protection Agency (EPA) for its flagship product, ContraPest.
“We intend to move rapidly to address the global opportunity facing us,” says Dr. Loretta Mayer, Chair, CEO and co-founder of SenesTech. “While continuing to work with key customers in the U.S., we intend to increase the attention and resources we are devoting to international markets. Dr. Alcaraz will be a key contributor to pursuing opportunities to leverage our EPA registration outside the U.S.”